Legend Biotech Income Statement (2019-2025) | LEGN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	0.01B	0.02B	0.02B	0.01B	0.01B	0.01B	0.04B	0.01B	0.02B	0.02B	0.04B	0.05B	0.01B	0.03B	0.03B	0.04B	0.07B	0.10B	79.46B	0.09B	0.19B	0.16B	186.52B	0.20B	0.26B	0.27B
Cost of Revenue	0.01B	0.00B	0.01B	0.01B	0.01B	0.01B	0.02B	13.42B	0.02B	0.02B	0.05B	0.02B	0.03B	0.02B	0.03B	0.02B	0.02B	0.02B	33.68B	0.02B	0.03B	0.04B	48.92B	0.04B	0.05B	0.05B
Gross Profit	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.02B	-13.40B	0.00B	-0.00B	-0.01B	0.03B	-0.02B	0.01B	0.00B	0.02B	0.05B	0.07B	45.79B	0.07B	0.16B	0.12B	137.60B	0.15B	0.21B	0.22B
Operating items
Research & Development	-0.03B	-0.04B	-0.07B	-0.05B	-0.05B	-0.06B	-0.07B	-0.00B	-0.08B	-0.07B	-0.09B	-0.08B	-0.07B	-0.10B	-0.08B	-0.08B	-0.10B	-0.10B	-0.00B	-0.10B	-0.11B	-0.10B	-0.00B	-0.10B	-0.10B	-0.11B
Share-based Compensation (IS)																			0.01B				0.01B
Selling, General & Administrative	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.03B	-0.02B	-0.03B	-0.03B	-0.00B	-0.03B	-0.04B	-0.04B	-0.00B	-0.03B	-0.03B	-0.03B
Operating Expenses	-0.03B	-0.04B	-0.07B	-0.05B	-0.06B	-0.07B	-0.08B	-0.00B	-0.09B	-0.08B	-0.10B	-0.09B	-0.09B	-0.13B	-0.11B	-0.11B	-0.12B	-0.12B	-0.00B	-0.13B	-0.15B	-0.13B	-0.00B	-0.13B	-0.13B	-0.15B
Operating Income	0.04B	0.06B	0.07B	0.06B	0.06B	0.07B	0.09B	-13.40B	0.10B	0.08B	0.09B	0.12B	0.07B	0.14B	0.11B	0.13B	0.18B	0.20B	45.79B	0.20B	0.30B	-0.07B	137.60B	0.29B	0.34B	-0.04B
EBIT	0.04B	0.06B	0.07B	0.06B	0.06B	0.07B	0.09B	-13.40B	0.10B	0.08B	0.09B	0.12B	0.07B	0.14B	0.11B	0.13B	0.18B	0.20B	45.79B	0.20B	0.30B	-0.07B	137.60B	0.29B	0.34B	-0.04B
Non-operating items
Interest & Investment Income						-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.02B		0.01B	0.02B	0.02B		-0.01B	0.01B	0.01B
Other Non Operating Income						0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	-0.00B	0.01B	0.01B	-0.00B	0.01B	0.04B	-0.05B	0.01B	-0.06B	-0.11B	0.06B	-0.11B	0.00B
Net income details
EBT	-0.03B	-0.03B	-0.06B	-0.05B	-0.13B	-0.07B	-0.31B	-0.00B	-0.09B	-0.12B	-0.41B	-0.03B	-0.19B	-0.08B	-0.14B	-0.11B	-0.20B	-0.06B	-0.00B	0.06B	-0.02B	-0.12B	0.04B	-0.10B	-0.12B	-0.04B
Tax Provisions	-0.00B		-0.00B			0.00B	-0.00B	0.00B	-0.00B		-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Profit After Tax	-0.03B	-0.03B	-0.06B	-0.04B	-0.13B	-0.07B	-0.06B	-0.00B	-0.09B	-0.12B	-0.09B	-0.03B	-0.19B	-0.08B	-0.14B	-0.11B	-0.20B	-0.06B	-0.00B	-0.06B	-0.02B	-0.13B	0.00B	-0.10B	-0.13B	-0.04B
Income from Continuing Operations	-0.03B	-0.03B	-0.06B	-0.05B	-0.13B	-0.07B	-0.31B	-0.00B	-0.09B	-0.12B	-0.40B	-0.03B	-0.19B	-0.08B	-0.14B	-0.11B	-0.20B	-0.06B	-0.00B	0.06B	-0.02B	-0.12B	0.04B	-0.10B	-0.12B	-0.04B
Consolidated Net Income	-0.03B	-0.03B	-0.06B	-0.05B	-0.13B	-0.07B	-0.31B	-0.00B	-0.09B	-0.12B	-0.40B	-0.03B	-0.19B	-0.08B	-0.14B	-0.11B	-0.20B	-0.06B	-0.00B	0.06B	-0.02B	-0.12B	0.04B	-0.10B	-0.12B	-0.04B
Income towards Parent Company	-0.03B	-0.03B	-0.06B	-0.04B	-0.13B	-0.07B	-0.06B	-0.00B	-0.09B	-0.12B	-0.09B	-0.03B	-0.19B	-0.08B	-0.14B	-0.11B	-0.20B	-0.06B	-0.00B	-0.11B	-0.20B	-0.13B	0.00B	-0.10B	-0.12B	-0.04B
Net Income towards Common Stockholders	-0.03B	-0.03B	-0.06B	-0.04B	-0.13B	-0.07B	-0.06B	-0.00B	-0.09B	-0.12B	-0.09B	-0.03B	-0.19B	-0.08B	-0.14B	-0.11B	-0.20B	-0.06B	-0.00B	-0.11B	-0.20B	-0.13B	0.00B	-0.10B	-0.12B	-0.04B
Additional items
EPS (Basic)	-0.14	-0.14	-0.32	-0.22	-0.63	-0.25	-0.24	-0.34	-0.33	-0.43	-0.31	-0.10			-0.43						-0.00B	-0.00B			-0.00B	-0.00B
EPS (Weighted Average and Diluted)	-0.14	-0.14	-0.32	-0.22	-0.63	-0.25	-0.22	-0.34	-0.33	-0.43	-0.30	-0.10									-0.00B	-0.00B			-0.00B	-0.00B
Shares Outstanding (Weighted Average)	0.20B	0.20B	0.20B	0.20B	0.22B	0.26B	0.24B	0.00B	0.28B	0.29B	0.28B	0.31B			0.32B						210.00	560.00			620.00	720.00
Shares Outstanding (Diluted Average)	0.20B	0.20B	0.20B	0.20B	0.22B	0.26B	0.26B	0.00B	0.28B	0.29B	0.29B	0.31B									210.00	560.00			620.00	720.00
EBITDA	0.04B	0.06B	0.07B	0.06B	0.06B	-0.07B	0.09B	-0.08B	-0.09B	-0.12B	0.09B	-0.04B	-0.18B	-0.09B	0.11B	-0.10B	-0.21B	-0.08B	45.79B	-0.11B	0.03B	0.06B	137.60B	0.06B	0.00B	0.04B
Interest Expenses	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.01B	-0.01B	-0.01B	-0.00B	0.01B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.01B
Tax Rate	1.18%		3.67%			-0.76%	0.02%	-4.31%	0.00%		0.89%	0.51%	0.08%	0.18%	0.11%	0.11%	0.15%	-0.46%	-1.36%	-0.01%	1.26%	3.67%	-0.04%	1.80%	0.47%	1.58%

Research Tools

Legend Biotech Income Statement (2019-2025) | LEGN

Create an account

Sign In

Reset Password